AHCO vs. RDNT, BTSG, SHC, SGRY, PRVA, CON, WGS, VCYT, ADUS, and PACS
Should you be buying AdaptHealth stock or one of its competitors? The main competitors of AdaptHealth include RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), GeneDx (WGS), Veracyte (VCYT), Addus HomeCare (ADUS), and PACS Group (PACS). These companies are all part of the "healthcare" industry.
AdaptHealth vs. Its Competitors
AdaptHealth (NASDAQ:AHCO) and RadNet (NASDAQ:RDNT) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.
AdaptHealth has a beta of 1.63, suggesting that its stock price is 63% more volatile than the S&P 500. Comparatively, RadNet has a beta of 1.41, suggesting that its stock price is 41% more volatile than the S&P 500.
AdaptHealth has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than AdaptHealth, indicating that it is currently the more affordable of the two stocks.
AdaptHealth has a net margin of 2.63% compared to RadNet's net margin of -1.73%. AdaptHealth's return on equity of 6.96% beat RadNet's return on equity.
82.7% of AdaptHealth shares are owned by institutional investors. Comparatively, 77.9% of RadNet shares are owned by institutional investors. 1.6% of AdaptHealth shares are owned by insiders. Comparatively, 5.6% of RadNet shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
In the previous week, RadNet had 1 more articles in the media than AdaptHealth. MarketBeat recorded 6 mentions for RadNet and 5 mentions for AdaptHealth. AdaptHealth's average media sentiment score of 0.91 beat RadNet's score of 0.63 indicating that AdaptHealth is being referred to more favorably in the media.
AdaptHealth presently has a consensus price target of $13.40, indicating a potential upside of 46.77%. RadNet has a consensus price target of $69.60, indicating a potential upside of 21.55%. Given AdaptHealth's higher probable upside, research analysts clearly believe AdaptHealth is more favorable than RadNet.
Summary
AdaptHealth beats RadNet on 12 of the 17 factors compared between the two stocks.
Get AdaptHealth News Delivered to You Automatically
Sign up to receive the latest news and ratings for AHCO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding AHCO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
AdaptHealth Competitors List
Related Companies and Tools
This page (NASDAQ:AHCO) was last updated on 7/17/2025 by MarketBeat.com Staff
Free AHCO Stock Alerts